Melanoma whole-exome sequencing identifies V600EB-RAF amplification-mediated acquired B-RAF inhibitor resistance 论文

2012Nature Communications引用 619顶会
DOIPDF
Melanoma and MAPK PathwaysHER2/EGFR in Cancer ResearchComputational Drug Discovery Methods
Computational Drug Discovery MethodsMelanoma and MAPK PathwaysHER2/EGFR in Cancer Research
相关技术:Computational Drug Discovery Methods
关系图谱

Melanoma whole-exome sequencing identifies V600EB-RAF amplification-mediated acquired B-RAF inhibitor resistance · 作者

R

Roger S. Lo

A

Antoni Ribas

S

Stanley F. Nelson

G

Georgina V. Long

R

Richard Kefford

J

Jeffrey A. Sosman

K

Kimberly B. Dahlman

R

Richard A. Scolyer

T

Thinle Chodon

C

Charles Ng

R

Richard C. Koya

H

Hane Lee

M

Mi‐Kyung Lee

X

Xiangju Kong

G

Gatien Moriceau

H

Hubing Shi